Literature DB >> 6034365

The reactivation by pyridium aldoximes of phosphorylated acetylcholinesterase in the central nervous system.

F Hobbiger, V Vojvodić.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6034365     DOI: 10.1016/0006-2952(67)90093-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  6 in total

Review 1.  Positron emission tomography studies of organophosphate chemical threats and oxime countermeasures.

Authors:  Charles M Thompson; John M Gerdes; Henry F VanBrocklin
Journal:  Neurobiol Dis       Date:  2019-04-22       Impact factor: 5.996

2.  Pralidoxime iodide (2-pAM) penetrates across the blood-brain barrier.

Authors:  Koichi Sakurada; Kazuo Matsubara; Keiko Shimizu; Hiroshi Shiono; Yasuo Seto; Koichiro Tsuge; Mineo Yoshino; Ikuko Sakai; Harutaka Mukoyama; Takehiko Takatori
Journal:  Neurochem Res       Date:  2003-09       Impact factor: 3.996

3.  Nanoparticulate transport of oximes over an in vitro blood-brain barrier model.

Authors:  Sylvia Wagner; Jürgen Kufleitner; Anja Zensi; Miriam Dadparvar; Sascha Wien; Judith Bungert; Tikva Vogel; Franz Worek; Jörg Kreuter; Hagen von Briesen
Journal:  PLoS One       Date:  2010-12-03       Impact factor: 3.240

4.  Acetylcholine content in the brain of rats treated with paraoxon and obidoxime.

Authors:  M P Milosević
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

5.  Penetration of oximes across the blood-brain barrier. A histochemical study of the cerebral cholinesterases reactivation.

Authors:  I S De la Manche; D E Vergé; C Bouchaud; H Coq; H Sentenac-Roumanou
Journal:  Experientia       Date:  1979-04-15

6.  Protection against diisopropylfluorophosphate intoxication by pyridostigmine and physostigmine in combination with atropine and mecamylamine.

Authors:  L Harris; D Stitcher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-08       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.